Question 1

What are the most cited papers from EndoProtech (United States)?

Accepted Answer

The most cited paper from EndoProtech (United States) is "Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench" (Walter E. Rodriguez, Banrida Wahlang, Yali Wang et al., 2019), with 60 citations. Next come "Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration" (17) and "Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis" (11).

Question 2

Which research topics does EndoProtech (United States) publish most on?

Accepted Answer

By volume in 2022-now: Phosphodiesterase function and regulation, Liver physiology and pathology, Liver Disease and Transplantation and Nausea and vomiting management.

Question 3

Which fields of science does EndoProtech (United States) work in?

Accepted Answer

In all years, 53% of research at EndoProtech (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (32%), Engineering (11%).

Question 4

Is EndoProtech (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 29% higher than in 2018-2021.